CALGARY, AB – Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) (“Nanalysis” or the “Company”) in accordance with its press release dated January 18, 2022, the Company announces that it has funded the initial equity investment in Quad Systems AG (“Quad Systems”), acquiring 43% ownership and an option to purchase the remaining shares. “We are happy to have closed this […]
Calgary, Alberta — (“Nanalysis” or the “Company”) in accordance with its press release dated January 18, 2022, the Company announces that it has funded the initial equity investment in Quad Systems AG (“Quad Systems”), acquiring 43% ownership and an option to purchase the remaining shares. “We are happy to have closed this initial portion of our […]
UTRECHT, Netherlands – The Dutch ultra-high field nuclear magnetic resonance consortium (uNMR-NL) is broadening its scientific research capabilities with a new Bruker 1.2 GHz Avance™ NMR system installed at Utrecht University. The uNMR-NL consortium consists of research groups at Utrecht University, Wageningen University, Radboud University, Leiden University, the private-public partnership COAST and associated members at the academic medical […]
CALGARY, AB — Nanalysis Scientific Corp. (“the Company”, TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR and MRI machines for healthcare and industrial applications, provides a corporate update and will be holding at call at 5:00pm ET today. “Our growth trajectory continued though the end of 2021 and continues today,” said Sean Krakiwksy, Chief Executive Office of Nanalysis. […]
Bruker Introduces Connexus: A NMR Capacity Sharing Cloud-based Platform for Collaboration between Scientists and Analytical Labs in Europe ZUERICH, Switzerland – Bruker BioSpin announces the introduction of Connexus® in Europe – a cloud-based collaboration platform that connects nuclear magnetic resonance (NMR) scientists in need of analytical services and data evaluation expertise with NMR laboratories with available […]
PARIS, France – Université de Paris has installed a new Bruker In Vitro Diagnostic research (IVDr) nuclear magnetic resonance (NMR) spectrometer within its MetaboParis-Santé platform located in the center of Paris city, France. One of the most prestigious universities in France, known for its cutting-edge research in medicine and more broadly biology and health, is […]
CALGARY, Alberta – Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) (“Nanalysis” or the “Company”) is pleased to announce that it has entered into a letter of intent to acquire QUAD Systems AG (Quad Systems), a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets. Quad Systems and Nanalysis have been working together […]
CALGARY, AB – Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) (“Nanalysis” or the “Company”) is pleased to announce that it has successfully closed the previously announced acquisition of K'(Prime) Technologies Inc. (KPrime), a North American sales and service company, with a particular focus on scientific instrumentation for pharma, food, chemical and oil & gas customers, […]
CALGARY, AB – Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) (“Nanalysis” or the “Company”) is pleased to announce that, effective December 21, 2021, it has established a Scientific Advisory Board, with four world renowned scientists as founding members, including Dr. Matt Rosen of Harvard Medical School and co-founder of Hyperfine. Nanalysis is a leader in miniaturized magnetic resonance systems for industrial […]
CALGARY, AB – Nanalysis Scientific Corp. (“Nanalysis” or the “Company”), TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) is pleased to announce that, effective January 1, 2022, Dr. René Lenggenhager, is joining its Board of Directors. Dr. Lenggenhager is an experienced public company executive and board member with a successful career in leading global technology companies. In addition, the Company is pleased to announce that […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
